Surprisingly, we found that FOXO6, but not FOXO1, 3, and 4, was frequently overexpressed in breast cell lines and tumours compared to normal cells, suggesting that this FOXO gene could act as an oncogene in human breast carcinogenesis. This evidence concerns the gene FOXO1 and neoplasm.